Drug profile · INN
hydrocodone bitartrate
HYDROCODONE BITARTRATE
hydrocodone bitartrate (HYDROCODONE BITARTRATE) is a opioid receptors; mu/kappa/delta agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — hydrocodone bitartrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 6
- Programs
- 9
- Data quality
- 0.89
Quick answer
hydrocodone bitartrate (HYDROCODONE BITARTRATE) is a opioid receptors; mu/kappa/delta agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Opioid receptors; mu/kappa/delta agonist
Primary target: Opioid receptors; mu/kappa/delta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 10092559
Abuse resistant pharmaceutical compositions
granted -
US 10028946
Treating pain in patients with hepatic impairment
granted -
US 9713611
Abuse resistant pharmaceutical compositions
granted -
US 9486451
Abuse resistant pharmaceutical compositions
granted -
US 9452163
Abuse resistant pharmaceutical compositions
granted -
US 9132096
Abuse resistant pharmaceutical compositions
granted
Frequently asked questions
What is hydrocodone bitartrate?
hydrocodone bitartrate (HYDROCODONE BITARTRATE) is a opioid receptors; mu/kappa/delta agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for hydrocodone bitartrate?
HYDROCODONE BITARTRATE is a marketed brand name for hydrocodone bitartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydrocodone bitartrate?
hydrocodone bitartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.